Otonomy Suspends Development of Lead Drug After Phase III Flop, Stock Plunges Post author:Sam Post published:August 29, 2017 Post category:BioPharma August 30, 2017By Alex Keown, BioSpace… Source: BioSpace You Might Also Like SoCal's Regulus Sinks After AstraZeneca PLC Bails on Lead NASH Drug June 11, 2017 <b>CROS NT</b> Launches CROScheck At DIA Chicago To Help Clinical Trial Sponsors Meet New ICH GCP E6(R2) Guidelines June 22, 2017 Future Biotech Giants: 11 Life Science Entrepreneurs Under 30 February 22, 2017
<b>CROS NT</b> Launches CROScheck At DIA Chicago To Help Clinical Trial Sponsors Meet New ICH GCP E6(R2) Guidelines June 22, 2017
